Evidence map›Paper›PMID 23168412›Full record

ArticleThe Journal of biological chemistry2013

Distinct roles of Ser-764 and Lys-773 at the N terminus of von Willebrand factor in complex assembly with coagulation factor VIII.

Lydia Castro-Núñez, Esther Bloem, Mariëtte G Boon-Spijker, Carmen van der Zwaan, Maartje van den Biggelaar, Koen Mertens, Alexander B Meijer

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Von Willebrand factor and hematogenous cancer metastasis under flow.Frontiers in cell and developmental biology · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. On the versatility of von Willebrand factor.Mediterranean journal of hematology and infectious diseases · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lydia Castro-NúñezDepartment of Plasma Proteins, Sanquin Research, 1066 CX Amsterdam, The Netherlands.
Esther Bloem
Mariëtte G Boon-Spijker
Carmen van der Zwaan
Maartje van den Biggelaar
Koen Mertens
Alexander B Meijer
Sanquin · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex formation between coagulation factor VIII (FVIII) and von Willebrand factor (VWF) is of critical importance to protect FVIII from rapid in vivo clearance and degradation. We have now employed a chemical footprinting approach to identify regions on VWF involved in FVIII binding. To this end, lysine amino acid residues of VWF were chemically modified in the presence of FVIII or activated FVIII, which does not bind VWF. Nano-LC-MS analysis showed that the lysine residues of almost all identified VWF peptides were not differentially modified upon incubation of VWF with FVIII or activated FVIII. However, Lys-773 of peptide Ser-766-Leu-774 was protected from chemical modification in the presence of FVIII. In addition, peptide Ser-764-Arg-782, which comprises the first 19 amino acid residues of mature VWF, showed a differential modification of both Lys-773 and the α-amino group of Ser-764. To verify the role of Lys-773 and the N-terminal Ser-764 in FVIII binding, we employed VWF variants in which either Lys-773 or Ser-764 was replaced with Ala. Surface plasmon resonance analysis and competition studies revealed that VWF(K773A) exhibited reduced binding to FVIII and the FVIII light chain, which harbors the VWF-binding site. In contrast, VWF(S764A) revealed more effective binding to FVIII and the FVIII light chain compared with WT VWF. The results of our study show that the N terminus of VWF is critical for the interaction with FVIII and that Ser-764 and Lys-773 have opposite roles in the binding mechanism.

Indexed as

Amino Acid SequenceBinding SitesDose-Response Relationship, DrugFactor VIIIHumansKineticsLysineMass SpectrometryMolecular ConformationMolecular Sequence DataProtein BindingProtein Structure, TertiarySequence Homology, Amino AcidSerineSurface Plasmon Resonancevon Willebrand FactorFactor VIIILysineSerinevon Willebrand Factor

Identifiers

PMID23168412
PMCPMC3537036
OpenAlexW2036307682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.